Media Outlet:
Science Publication Date:
Description:
In an article for Science, Jocelyn Kaiser writes about how Prof. Robert Weinberg’s company, Verastem Inc., is starting a new round of clinical trials to test the theory that by targeting cancer stem cells, the disease can be controlled.